Clinical trial Recruiting at 2 sites Phase 2 Interventional Ages 18 to 45 Women only

Monthly penicillin to prevent syphilis during pregnancy

Official title: Evaluation of Antimicrobial Prophylaxis to Prevent Syphilis in Pregnancy in Patients at Risk in Rio de Janeiro, Brazil

Run by University of California, Los Angeles · NCT07189208 · Data updated 2026-11-12

This trial will test whether monthly benzathine penicillin injections plus counseling in the third trimester can prevent syphilis in pregnant people at higher risk.

Quick facts

PhasePhase 2
Study typeInterventional
Ages18 Years to 45 Years
SexWomen only
Enrollment500 (estimated)
SponsorUniversity of California, Los Angeles
Academic / other
Locations4 sites (Duque de Caxias, Rio de Janeiro and 3 other locations)
StatusRecruiting
StartedSeptember 24, 2025
Main results expectedDecember 1, 2029
Study endsJuly 31, 2030
Registry record updatedJune 1, 2026
Trial IDNCT07189208 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Pregnant people with a viable pregnancy who are negative for syphilis at baseline, meet one or more elevated-risk criteria (for example recent STI history, HIV infection, age under 21, recent new partners, late prenatal care, or residence in a high-prevalence area), can consent, and can attend monthly prenatal visits at a participating site are ideal candidates.

Probably not a fit

People with a positive baseline syphilis test, a penicillin allergy, non-viable or very high-risk pregnancies, lack of sexual activity during the study period, or contraindications to IM injections would not be expected to benefit from this prophylaxis.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a randomized, unblinded Phase 2 trial comparing monthly intramuscular benzathine penicillin G (2.4 million units) plus enhanced counseling and testing to enhanced standard of care (counseling and monthly treponemal and non-treponemal tests) beginning at 28 weeks of pregnancy. Participants who are negative for syphilis at baseline and meet prespecified risk criteria will receive monthly clinic visits for testing and injections through delivery. The primary maternal endpoint is absence of treponemal and non-treponemal evidence of syphilis at delivery, and the primary infant endpoint is absence of congenital syphilis. Safety monitoring will record adverse reactions to penicillin and any pregnancy-related complications.

Why it matters

Potential benefit: If successful, this approach could lower maternal syphilis rates and reduce cases of congenital syphilis and related infant illness.

How similar studies have gone: Using routine monthly benzathine penicillin as prophylaxis in pregnancy is a relatively novel approach with limited prior trial data and has not been widely tested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Uncomplicated, viable pregnancy
2. Elevated risk for syphilis acquisition (one or more of the following):

   1. Prior history of STIs last 3 years
   2. HIV infection
   3. Age \< 21 years
   4. In a sexual partnership of \< 3 mo., or \> 3 sexual partners in the last 6 mo.
   5. Late initiation of prenatal care (\> 14 weeks of pregnancy)
   6. Residence in area where syphilis prevalence is 10% or higher.
3. Ability to provide written informed consent
4. No allergy to penicillin
5. Prenatal care at one of the sites participating in the study
6. Ongoing sexual activity during study period.
7. Negative rapid treponemal test at baseline.

Exclusion Criteria:

1. Non-viable pregnancy
2. Very high risk pregnancy
3. Inability to provide written informed consent
4. Allergy to penicillin
5. Positive rapid treponemal test at baseline
6. Lack of sexual activity during study period.
7. Any persisting coagulation disorder that would contraindicate IM injections.

Where it's running

  • Policlínica Hospital Municipal Duque de Caxias
    Duque de Caxias, Rio de Janeiro, Brazil
    Recruiting
  • Hospital Federal dos Servidores do Estado
    Rio de Janeiro, Rio de Janeiro, Brazil
    Recruiting
  • Centro de Referencia e Atenção Especializada a Saúde da Mulher (CRAESM)
    Duque de Caxias, Rio de Janeiro, Brazil
    Not yet recruiting
  • Unidade Básica de Saúde José de Freitas
    Duque de Caxias, Rio de Janeiro, Brazil
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.